{"id":17688,"date":"2026-02-11T19:19:43","date_gmt":"2026-02-11T19:19:43","guid":{"rendered":"https:\/\/dndial.org\/?post_type=projetos&p=17688"},"modified":"2026-04-20T19:18:30","modified_gmt":"2026-04-20T19:18:30","slug":"lxe408-novartis-para-leishmaniasis-cutanea","status":"publish","type":"projetos","link":"https:\/\/dndial.org\/es\/projetos\/lxe408-novartis-para-leishmaniasis-cutanea\/","title":{"rendered":"LXE408 (Novartis) para leishmaniasis cut\u00e1nea"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n Home<\/a>   »   Nuestros proyectos<\/a>   »   LXE408 (Novartis) para leishmaniasis cut\u00e1nea<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n \n
\n
\n
\n
\n
\n
\n \"Leishmaniasis\n <\/div>\n
\n \n \n Leishmaniasis cut\u00e1nea <\/a><\/small>\n

\n LXE408 (Novartis) para leishmaniasis cut\u00e1nea<\/h1>\n <\/div>\n <\/div>\n
\n \n <\/i><\/a>\n \n <\/i><\/a>\n \n <\/i><\/a>\n \n <\/a>\n <\/i><\/a>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n
\n

\n Inicio del proyecto<\/h3>\n 2024<\/span>\n <\/div>\n
\n

\n Actualizado el<\/h3>\n 7 de febrero de 2025<\/span>\n <\/div>\n <\/div>\n

Objetivo <\/h3>\n Evaluar la idoneidad de LXE408 para el tratamiento de pacientes con leishmaniasis cut\u00e1nea localizada<\/span>\n

\n Fase actual de desarrollo de f\u00e1rmacos <\/h3>\n
\n
\n \n Discovery <\/div>\n <\/div>\n
\n \n Pesquisa Translacional <\/div>\n <\/div>\n
\n \n Ensaios Cl\u00ednicos <\/div>\n <\/div>\n
\n \n Registro e Acesso <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\n <\/div>\n